2026 COVID-19 Health Outcomes Patient Satisfaction 
HIT Consultant
AUGUST 16, 2022
Moreover, cancer screenings, and most notably, mammograms, drastically decreased during the COVID-19 pandemic as many healthcare facilities were temporarily closed and others faced severe staffing shortages.
Healthcare IT Today
AUGUST 26, 2022
The acquisition will expand Intelerad’s product offerings for mammography and lung analytics, optimizing workflows for radiologists and boosting health outcomes for patients. billion by 2026. PenRad is at the front lines of care as demand surges. The acquisition of PenRad is an exciting milestone for Intelerad.
Expert insights. Personalized for you.
52 
Let's personalize your content